Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,701.60
Bid: 1,698.20
Ask: 1,699.00
Change: 0.00 (0.00%)
Spread: 0.80 (0.05%)
Open: 1,709.60
High: 1,715.00
Low: 1,691.80
Yest. Close: 1,696.60
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Teva's UK arm recalls some batches of Ranitidine - Medicines watchdog

Thu, 17th Oct 2019 15:50

Oct 17 (Reuters) - Teva Pharmaceutical's
UK unit has recalled some batches of heartburn medicine
Ranitidine, Britain's medicines watchdog said on Thursday,
making it the latest drugmaker to pull the product.

Teva, the world's largest generic drugmaker, is recalling
all unexpired stock of Ranitidine Effervescent Tablets in 150
micrograms and 300 micrograms dosages, the Medicines and
Healthcare products Regulatory Agency (MHRA) said https://www.gov.uk/government/news/ranitidine-mhra-drug-alert-issued-for-teva-uk-recall.

Teva did not immediately respond to a request for comment.

Rantidine, a copycat of GlaxoSmithKline's Zantac, is
being taken off the shelves after the U.S. Food and Drug
Administration found "unacceptable" levels of a probable
cancer-causing impurity in the drug.

GSK last week recalled Zantac in all markets.

U.S. and European health regulators said last month they
were reviewing the safety of Ranitidine, after online pharmacy
Valisure warned of possible contamination with an impurity
called NDMA, which has carcinogenic potential.

Ranitidine is the latest drug in which cancer-causing
impurities have been found. Regulators have been recalling some
blood pressure and heart failure medicines since last year.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Bernard
Orr)

More News

Thursday broker round-up

(Sharecast News) - Fevertree: Deutsche Bank downgrades to hold with a target price of 2,200p.

21 Nov 19 13:05

LONDON MARKET MIDDAY: China Threatens Retaliation Over Hong Kong Bill

LONDON MARKET MIDDAY: China Threatens Retaliation Over Hong Kong Bill

21 Nov 19 12:03

Sanofi weighing options for consumer healthcare unit-sources

By Arno Schuetze and Matthias BlamontFRANKFURT/PARIS, Nov 21 (Reuters) - Sanofi is considering a joint venture or outright sale among options for its consumer healthcare unit, sources told Reuters, as the French drugmaker prepares to present a new...

21 Nov 19 11:42

UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva

UK BROKER RATINGS SUMMARY: UBS High On Glaxo, Deutsche Down On Aviva

21 Nov 19 09:38

Friday broker round-up

(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.

15 Nov 19 13:09

UK BROKER RATINGS SUMMARY: Jefferies And JPMorgan Both Cut Tullow Oil

UK BROKER RATINGS SUMMARY: Jefferies And JPMorgan Both Cut Tullow Oil

14 Nov 19 09:21

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

7 Nov 19 16:10

Thursday broker round-up

(Sharecast News) - Associated British Foods: Goldman Sachs upgrades to buy with a target price of 2,750p.

7 Nov 19 13:28

DIRECTOR DEALINGS: GlaxoSmithKline Divisional Presidents Sell Shares

DIRECTOR DEALINGS: GlaxoSmithKline Divisional Presidents Sell Shares

4 Nov 19 18:37

Liberum hikes target price for GSK but stays at hold

(Sharecast News) - Analysts at Liberum hiked their target price for shares of GlaxoSmithKline after switching valuation methods given the company's medium-term plans to split its Consumer Health business from its Pharmaceuticals arm.

4 Nov 19 15:50

UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

UK BROKER RATINGS SUMMARY: Peel Hunt Initiates Whitbread With Buy

4 Nov 19 09:10

UK BROKER RATINGS SUMMARY: UBS Cuts Euromoney And Crest Nicholson

UK BROKER RATINGS SUMMARY: UBS Cuts Euromoney And Crest Nicholson

1 Nov 19 09:27

DIRECTOR DEALINGS: GlaxoSmithKline Communication Head Sells Shares

DIRECTOR DEALINGS: GlaxoSmithKline Communication Head Sells Shares

31 Oct 19 14:59

UK BROKER RATINGS SUMMARY: DZ Bank And Credit Suisse Up Glaxo Target

UK BROKER RATINGS SUMMARY: DZ Bank And Credit Suisse Up Glaxo Target

31 Oct 19 09:27

CORRECT: LONDON BRIEFING: IAG Takes EUR155 Million Hit From Strike

CORRECT: LONDON BRIEFING: IAG Takes EUR155 Million Hit From Strike

31 Oct 19 08:10

Login to your account

Don't have an account? Click here to register.